Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Clinical utility of circulating interleukin-6 concentrations in the detection of functionally relevant coronary artery disease.

Walter J, Tanglay Y, du Fay de Lavallaz J, Strebel I, Boeddinghaus J, Twerenbold R, Doerflinger S, Puelacher C, Nestelberger T, Wussler D, Amrein M, Badertscher P, Todd J, Rentsch K, Fahrni G, Jeger R, Kaiser C, Reichlin T, Mueller C.

Int J Cardiol. 2018 Oct 12. pii: S0167-5273(18)33851-8. doi: 10.1016/j.ijcard.2018.10.029. [Epub ahead of print]

PMID:
30340850
2.

Temporal Trends in Adoption and Outcomes of Transcatheter Aortic Valve Implantation: A Swisstavi Registry Analysis.

Stortecky S, Franzone A, Heg D, Tueller D, Noble S, Pilgrim T, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Muller O, Huber C, Roffi M, Carrel T, Wenaweser P, Windecker S.

Eur Heart J Qual Care Clin Outcomes. 2018 Oct 9. doi: 10.1093/ehjqcco/qcy048. [Epub ahead of print]

PMID:
30304513
3.

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.

Jeger RV, Farah A, Ohlow MA, Mangner N, Möbius-Winkler S, Leibundgut G, Weilenmann D, Wöhrle J, Richter S, Schreiber M, Mahfoud F, Linke A, Stephan FP, Mueller C, Rickenbacher P, Coslovsky M, Gilgen N, Osswald S, Kaiser C, Scheller B; BASKET-SMALL 2 Investigators.

Lancet. 2018 Sep 8;392(10150):849-856. doi: 10.1016/S0140-6736(18)31719-7. Epub 2018 Aug 28.

PMID:
30170854
4.

Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Approach in the Detection of Functionally Relevant Coronary Artery Disease.

Mueller D, Puelacher C, Honegger U, Walter JE, Badertscher P, Schaerli N, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Hollenstein C, du Fay de Lavallaz J, Jeger R, Kaiser C, Wild D, Rentsch K, Buser A, Zellweger M, Reichlin T, Mueller C.

Clin Chem. 2018 Nov;64(11):1596-1606. doi: 10.1373/clinchem.2018.286971. Epub 2018 Aug 10.

PMID:
30097496
5.

Supra-annular sizing for transcatheter valve implantation in bicuspid aortic stenosis.

Jeger R, Reuthebuch O, Fahrni G, Laborde JC, Vogel R, Kaiser C.

Postepy Kardiol Interwencyjnej. 2018;14(2):187-190. doi: 10.5114/aic.2018.76411. Epub 2018 Jun 19. No abstract available.

6.

Stents in saphenous vein grafts.

Jeger RV, Möbius-Winkler S.

Lancet. 2018 May 19;391(10134):1967-1968. doi: 10.1016/S0140-6736(18)30937-1. Epub 2018 May 11. No abstract available.

PMID:
29759511
7.

New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis.

Biasco L, Radovanovic D, Moccetti M, Rickli H, Roffi M, Eberli F, Jeger R, Moccetti T, Erne P, Pedrazzini G.

Rev Esp Cardiol (Engl Ed). 2018 Apr 10. pii: S1885-5857(18)30079-3. doi: 10.1016/j.rec.2018.03.002. [Epub ahead of print] English, Spanish.

PMID:
29653777
8.

Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.

Gilgen N, Farah A, Scheller B, Ohlow MA, Mangner N, Weilenmann D, Wöhrle J, Jamshidi P, Leibundgut G, Möbius-Winkler S, Zweiker R, Krackhardt F, Butter C, Bruch L, Kaiser C, Hoffmann A, Rickenbacher P, Mueller C, Stephan FP, Coslovsky M, Jeger R; BASKET-SMALL 2 Investigators.

Clin Cardiol. 2018 May;41(5):569-575. doi: 10.1002/clc.22942. Epub 2018 May 10.

9.

A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis.

Paul A, Krelin Y, Arif T, Jeger R, Shoshan-Barmatz V.

Mol Ther. 2018 Mar 7;26(3):680-694. doi: 10.1016/j.ymthe.2017.12.020. Epub 2017 Dec 24.

PMID:
29396267
10.

Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative.

Chandrasekhar J, Baber U, Sartori S, Stefanini GG, Sarin M, Vogel B, Farhan S, Camenzind E, Leon MB, Stone GW, Serruys PW, Wijns W, Steg PG, Weisz G, Chieffo A, Kastrati A, Windecker S, Morice MC, Smits PC, von Birgelen C, Mikhail GW, Itchhaporia D, Mehta L, Kim HS, Valgimigli M, Jeger RV, Kimura T, Galatius S, Kandzari D, Dangas G, Mehran R.

JACC Cardiovasc Interv. 2018 Jan 8;11(1):53-65. doi: 10.1016/j.jcin.2017.11.020.

PMID:
29301648
11.

Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials.

Faggioni M, Baber U, Afshar AE, Giustino G, Sartori S, Sorrentino S, Steg PG, Stefanini GG, Windecker S, Leon MB, Stone GW, Wijns W, Serruys PW, Valgimigli M, Camenzind E, Weisz G, Smits PC, Kandzari DE, Galatius S, Von Birgelen C, Jeger RV, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Dangas GD, Morice MC, Mehran R.

JACC Cardiovasc Interv. 2018 Jan 8;11(1):68-76. doi: 10.1016/j.jcin.2017.06.060. Epub 2017 Dec 13.

PMID:
29248412
12.

Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model.

Pilgrim T, Franzone A, Stortecky S, Nietlispach F, Haynes AG, Tueller D, Toggweiler S, Muller O, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M, Grünenfelder J, Huber C, Wenaweser P, Windecker S.

Circ Cardiovasc Interv. 2017 Nov;10(11). pii: e005481. doi: 10.1161/CIRCINTERVENTIONS.117.005481.

PMID:
29127116
13.

Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus.

Zellweger MJ, Haaf P, Maraun M, Osterhues HH, Keller U, Müller-Brand J, Jeger R, Pfister O, Brinkert M, Burkard T, Pfisterer M; BARDOT Investigators.

Int J Cardiol. 2017 Oct 1;244:37-42. doi: 10.1016/j.ijcard.2017.05.069.

14.

Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials.

Mangione FM, Biering-Sørensen T, Nochioka K, Jatene T, Silvestre OM, Hansen KW, Sørensen R, Jensen JS, Jorgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S.

Catheter Cardiovasc Interv. 2018 Apr 1;91(5):867-873. doi: 10.1002/ccd.27200. Epub 2017 Jul 19.

PMID:
28722266
15.

Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.

Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, Windecker S, Serruys PW, Kastrati A, Von Birgelen C, Kimura T, Stefanini GG, Dangas GD, Wijns W, Steg PG, Morice MC, Camenzind E, Weisz G, Smits PC, Sorrentino S, Sharma M, Farhan S, Faggioni M, Kandzari D, Galatius S, Jeger RV, Valgimigli M, Itchhaporia D, Mehta L, Kim HS, Chieffo A, Mehran R.

JAMA Cardiol. 2017 Aug 1;2(8):855-862. doi: 10.1001/jamacardio.2017.1978.

16.

Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry.

Jeger RV, Pfister O, Radovanovic D, Eberli FR, Rickli H, Urban P, Pedrazzini G, Stauffer JC, Nossen J, Erne P; AMIS-Plus Investigators.

Clin Cardiol. 2017 Oct;40(10):907-913. doi: 10.1002/clc.22745. Epub 2017 Jun 9.

17.

Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.

Hengstenberg C, Chandrasekhar J, Sartori S, Lefevre T, Mikhail G, Meneveau N, Tron C, Jeger R, Kupatt C, Vogel B, Farhan S, Sorrentino S, Sharma M, Snyder C, Husser O, Boekstegers P, Hambrecht R, Widder J, Hildick-Smith D, De Carlo M, Wijngaard P, Deliargyris E, Bernstein D, Baber U, Mehran R, Anthopoulos P, Dangas G; BRAVO-3 Investigators.

Catheter Cardiovasc Interv. 2017 Nov 15;90(6):1027-1037. doi: 10.1002/ccd.27155. Epub 2017 Jun 20.

PMID:
28493641
18.

Vollständig resorbierbare Stents – eine neue Ära in der Behandlung der koronaren Herzkrankheit?

Sabti Z, Jeger R.

Praxis (Bern 1994). 2017 Jan;106(2):85-89. doi: 10.1024/1661-8157/a002584. German. No abstract available.

PMID:
28103170
19.

The Neurocardiogenic Spectrum in Subarachnoid Hemorrhage: A Case Report and Review of the Literature.

Mansella G, Jeger R, Bingisser R, Nickel CH.

Clin Pract Cases Emerg Med. 2017 Jan 18;1(1):16-21. doi: 10.5811/cpcem.2016.11.32582. eCollection 2017 Mar.

20.

Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis.

Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Jüni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M.

EuroIntervention. 2017 Apr 7;12(18):e2170-e2176. doi: 10.4244/EIJ-D-16-00677.

21.

First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study.

Jeger R, Pfisterer M, Pfister O, Rickenbacher P, Handke M, Gilgen N, Coslovsky M, Kaiser C.

Postepy Kardiol Interwencyjnej. 2016;12(4):314-320. Epub 2016 Nov 17.

22.

Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.

Pilgrim T, Stortecky S, Nietlispach F, Heg D, Tueller D, Toggweiler S, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M, Grünenfelder J, Huber C, Wenaweser P, Windecker S.

J Am Heart Assoc. 2016 Nov 17;5(11). pii: e004088.

23.

Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials).

Jatene T, Biering-Sørensen T, Nochioka K, Mangione FM, Hansen KW, Sørensen R, Jensen JS, Jørgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators.

Am J Cardiol. 2017 Jan 1;119(1):14-19. doi: 10.1016/j.amjcard.2016.09.013. Epub 2016 Sep 29.

PMID:
27788931
24.

Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.

Giustino G, Mastoris I, Baber U, Sartori S, Stone GW, Leon MB, Serruys PW, Kastrati A, Windecker S, Valgimigli M, Dangas GD, Von Birgelen C, Smits PC, Kandzari D, Galatius S, Wijns W, Steg PG, Stefanini GG, Aquino M, Morice MC, Camenzind E, Weisz G, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Chieffo A, Mehran R.

JACC Cardiovasc Interv. 2016 Sep 26;9(18):1890-901. doi: 10.1016/j.jcin.2016.06.022.

25.

Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study.

Nochioka K, Biering-Sørensen T, Hansen KW, Sørensen R, Pedersen S, Jørgensen PG, Iversen A, Shimokawa H, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators.

Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):778-786. doi: 10.1177/2048872616649860. Epub 2016 May 10.

PMID:
27166320
26.

Sex-based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO-3 randomized trial.

Asgar A, Chandrasekhar J, Mikhail G, Webb J, Lefèvre T, Tamburino C, Hildick-Smith D, Hambrecht R, Van Belle E, Widder J, Dumonteil N, Hink U, Jeger R, Linke A, Deliargyris E, Gao P, Mehran R, Hengstenberg C, Anthopoulos P, Dangas G; BRAVO-3 Investigators.

Catheter Cardiovasc Interv. 2017 Jan;89(1):144-153. doi: 10.1002/ccd.26607. Epub 2016 Aug 16.

PMID:
27152677
27.

Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis.

Giustino G, Baber U, Aquino M, Sartori S, Stone GW, Leon MB, Genereux P, Dangas GD, Chandrasekhar J, Kimura T, Salianski O, Stefanini GG, Steg PG, Windecker S, Wijns W, Serruys PW, Valgimigli M, Morice MC, Camenzind E, Weisz G, Smits PC, Kandzari DE, Galatius S, Von Birgelen C, Saporito R, Jeger RV, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Mehran R.

JACC Cardiovasc Interv. 2016 Apr 11;9(7):674-84. doi: 10.1016/j.jcin.2015.12.013.

28.

Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off.

Bossard M, Jeger R.

J Thorac Dis. 2015 Dec;7(12):E625-8. doi: 10.3978/j.issn.2072-1439.2015.12.44. No abstract available.

29.

Incidence and Predictors of Cardiomyocyte Injury in Elective Coronary Angiography.

Kreutzinger P, Wildi K, Twerenbold R, Rubini Gimenez M, Reichlin T, Jaeger C, Hillinger P, Boeddinghaus J, Nestelberger T, Puelacher C, Stallone F, Rentsch K, Osswald S, Jeger R, Kaiser C, Mueller C.

Am J Med. 2016 May;129(5):537.e1-8. doi: 10.1016/j.amjmed.2015.12.010. Epub 2016 Jan 4.

PMID:
26763753
30.

Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.

Baber U, Giustino G, Sartori S, Aquino M, Stefanini GG, Steg PG, Windecker S, Leon MB, Wijns W, Serruys PW, Valgimigli M, Stone GW, Dangas GD, Morice MC, Camenzind E, Weisz G, Smits PC, Kandzari D, Von Birgelen C, Mastoris I, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Mehran R.

JACC Cardiovasc Interv. 2016 Jan 11;9(1):28-38. doi: 10.1016/j.jcin.2015.09.023.

31.

Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis.

Giustino G, Baber U, Salianski O, Sartori S, Stone GW, Leon MB, Aquino M, Stefanini GG, Steg PG, Windecker S, O' Donoghue M, Wijns W, Serruys PW, Valgimigli M, Morice MC, Camenzind E, Weisz G, Smits PC, Kandzari D, Von Birgelen C, Dangas GD, Cha JY, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Genereux P, Chieffo A, Mehran R.

Circ Cardiovasc Interv. 2016 Jan;9(1):e002995. doi: 10.1161/CIRCINTERVENTIONS.115.002995.

32.

Toxicopathological Effects of the Sunscreen UV Filter, Oxybenzone (Benzophenone-3), on Coral Planulae and Cultured Primary Cells and Its Environmental Contamination in Hawaii and the U.S. Virgin Islands.

Downs CA, Kramarsky-Winter E, Segal R, Fauth J, Knutson S, Bronstein O, Ciner FR, Jeger R, Lichtenfeld Y, Woodley CM, Pennington P, Cadenas K, Kushmaro A, Loya Y.

Arch Environ Contam Toxicol. 2016 Feb;70(2):265-88. doi: 10.1007/s00244-015-0227-7.

PMID:
26487337
33.

Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.

Dangas GD, Lefèvre T, Kupatt C, Tchetche D, Schäfer U, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Mehran R, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Fach A, Jeger R, Sardella G, Hink HU, Husser O, Grube E, Deliargyris EN, Lechthaler I, Bernstein D, Wijngaard P, Anthopoulos P, Hengstenberg C; BRAVO-3 Investigators.

J Am Coll Cardiol. 2015 Dec 29;66(25):2860-2868. doi: 10.1016/j.jacc.2015.10.003. Epub 2015 Oct 15.

34.

Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves.

Binder RK, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Pedrazzini G, Amann FW, Ferrari E, Noble S, Nietlispach F, Maisano F, Räber L, Roffi M, Grünenfelder J, Jüni P, Huber C, Windecker S, Wenaweser P.

Circ Cardiovasc Interv. 2015 Oct;8(10). pii: e002653. doi: 10.1161/CIRCINTERVENTIONS.115.002653.

35.

Letter by Jeger and Pfisterer regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement".

Jeger RV, Pfisterer ME.

Circulation. 2015 Sep 29;132(13):e165. doi: 10.1161/CIRCULATIONAHA.114.014988. No abstract available.

PMID:
26416638
36.

Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial.

Kurz DJ, Bernheim AM, Tüller D, Zbinden R, Jeger R, Kaiser C, Galatius S, Hansen KW, Alber H, Pfisterer M, Eberli FR.

Am Heart J. 2015 Oct;170(4):787-795.e1. doi: 10.1016/j.ahj.2015.07.009. Epub 2015 Jul 17.

PMID:
26386803
37.

Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.

Giustino G, Baber U, Stefanini GG, Aquino M, Stone GW, Sartori S, Steg PG, Wijns W, Smits PC, Jeger RV, Leon MB, Windecker S, Serruys PW, Morice MC, Camenzind E, Weisz G, Kandzari D, Dangas GD, Mastoris I, Von Birgelen C, Galatius S, Kimura T, Mikhail G, Itchhaporia D, Mehta L, Ortega R, Kim HS, Valgimigli M, Kastrati A, Chieffo A, Mehran R.

Am J Cardiol. 2015 Sep 15;116(6):845-52. doi: 10.1016/j.amjcard.2015.06.010. Epub 2015 Jun 24.

PMID:
26174605
38.

Duration of dual antiplatelet therapy after drug-eluting stents.

Pfisterer M, Kaiser C, Jeger R.

N Engl J Med. 2015 Apr 2;372(14):1372. doi: 10.1056/NEJMc1501195. No abstract available.

PMID:
25830433
39.

Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations.

Jeger RV, Pfisterer ME, Sørensen R, von Felten S, Alber H, Bonetti PO, Eberli F, Erne P, Pedrazzini G, Rickli H, Galatius S, Kaiser CA; BASKET and BASKET-PROVE investigators.

Am Heart J. 2014 Nov;168(5):698-705. doi: 10.1016/j.ahj.2014.07.019. Epub 2014 Jul 30.

PMID:
25440798
40.

Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial.

Kaiser C, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz DJ, Pedrazzini G, Moccetti T, Rickli H, Weilenmann D, Vuillomenet A, Steiner M, Von Felten S, Vogt DR, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M; BASKET-PROVE II study group.

Circulation. 2015 Jan 6;131(1):74-81. doi: 10.1161/CIRCULATIONAHA.114.013520. Epub 2014 Nov 19.

PMID:
25411159
41.

Interventional treatment for structural heart disease: who is deciding, and can we afford it?

Jeger R, Toggweiler S.

Swiss Med Wkly. 2014 Nov 15;144:w14046. doi: 10.4414/smw.2014.14046. eCollection 2014. Review.

42.

Single-center experience and short-term outcome with the JenaValve: a second-generation transapical transcatheter aortic valve implantation device.

Reuthebuch O, Inderbitzin DT, Rüter F, Jeger R, Kaiser C, Buser P, Fassl J, Eckstein FS.

Innovations (Phila). 2014 Sep-Oct;9(5):368-74; discussion 374. doi: 10.1097/IMI.0000000000000100.

PMID:
25251551
43.

Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.

Zellweger MJ, Maraun M, Osterhues HH, Keller U, Müller-Brand J, Jeger R, Pfister O, Burkard T, Eckstein F, von Felten S, Osswald S, Pfisterer M.

JACC Cardiovasc Imaging. 2014 Oct;7(10):1001-10. doi: 10.1016/j.jcmg.2014.07.010. Epub 2014 Sep 17.

44.

Pacemaker implantation and need for ventricular pacing during follow-up after transcatheter aortic valve implantation.

Ramazzina C, Knecht S, Jeger R, Kaiser C, Schaer B, Osswald S, Sticherling C, Kühne M.

Pacing Clin Electrophysiol. 2014 Dec;37(12):1592-601. doi: 10.1111/pace.12505. Epub 2014 Sep 16.

PMID:
25223835
45.

Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry.

Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Lüscher TF, Moat N, Price S, Dall'Ara G, Winter R, Corti R, Grasso C, Snow TM, Jeger R, Blankenberg S, Settergren M, Tiroch K, Balzer J, Petronio AS, Büttner HJ, Ettori F, Sievert H, Fiorino MG, Claeys M, Ussia GP, Baumgartner H, Scandura S, Alamgir F, Keshavarzi F, Colombo A, Maisano F, Ebelt H, Aruta P, Lubos E, Plicht B, Schueler R, Pighi M, Di Mario C; Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology.

J Am Coll Cardiol. 2014 Sep 2;64(9):875-84. doi: 10.1016/j.jacc.2014.06.1166.

46.

Prognostic value of "routine" cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING study.

Zellweger MJ, Fahrni G, Ritter M, Jeger RV, Wild D, Buser P, Kaiser C, Osswald S, Pfisterer ME; BASKET Investigators.

JACC Cardiovasc Interv. 2014 Jun;7(6):615-21. doi: 10.1016/j.jcin.2014.01.161. Epub 2014 May 14.

47.

Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry.

Wenaweser P, Stortecky S, Heg D, Tueller D, Nietlispach F, Falk V, Pedrazzini G, Jeger R, Reuthebuch O, Carrel T, Räber L, Amann FW, Ferrari E, Toggweiler S, Noble S, Roffi M, Gruenenfelder J, Jüni P, Windecker S, Huber C.

EuroIntervention. 2014 Dec;10(8):982-9. doi: 10.4244/EIJV10I8A166.

48.

First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve.

Jeger RV, Manoharan G, Kaiser CA.

EuroIntervention. 2014 Mar 20;9(11):1368. doi: 10.4244/EIJV9I11A229. No abstract available.

49.

Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.

Jeger R, Jaguszewski M, Nallamothu BN, Lüscher TF, Urban P, Pedrazzini GB, Erne P, Radovanovic D; AMIS Plus Investigators.

Int J Cardiol. 2014 Mar 1;172(1):76-81. doi: 10.1016/j.ijcard.2013.12.083. Epub 2014 Jan 4.

PMID:
24461983
50.

Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse?

Jaguszewski M, Radovanovic D, Nallamothu BK, Lüscher TF, Urban P, Eberli FR, Bertel O, Pedrazzini GB, Windecker S, Jeger R, Erne P; AMIS Plus Investigators.

EuroIntervention. 2013 Dec;9(8):909-15. doi: 10.4244/EIJV9I8A153.

Supplemental Content

Support Center